Root Financial Partners
PCRX icon

Root Financial Partners’s Pacira BioSciences PCRX Stock Holding History

Root Financial Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25 Buy
+1
New +$25 ﹤0.01% 3775
2026
Q2 		– Sell
-16
Closed -$362 – 2366
2026
Q1 		$362 Buy
+16
New +$356 ﹤0.01% 2975

Other funds holding PCRX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $13B AUM 14.15% 1-Year Est. Return
Gagnon Securities
Gagnon Securities New York $577M AUM 61.61% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Root Financial Partners's PCRX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Pacira BioSciences (PCRX) in Q3 2026: 1 share worth $25. The stake represents ﹤0.01% of the portfolio and ranks #3775 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in PCRX as recently as Q1 2026.

Root Financial Partners first reported a position in PCRX in Q1 2026 and has held it in 2 quarters since. The position peaked at $362 in Q1 2026. 138 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Root Financial Partners held 1 share of Pacira BioSciences worth $25 as of Q3 2026.
  • Pacira BioSciences was a new Root Financial Partners position in Q3 2026.
  • Pacira BioSciences made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3775 holding.
  • Root Financial Partners first reported a position in Pacira BioSciences in Q1 2026 and has held it in 2 quarters since.
  • Root Financial Partners's Pacira BioSciences position peaked at $362 in Q1 2026.
  • 138 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.